NDC 54771-8550 - Temaril-P
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54771-8550
- Package NDCs from labels
- 54771-8550-1, 54771-8550-2
- Manufacturer
- Zoetis Inc.
- Effective date
- 2023-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Temaril-P ® | Zoetis Inc. | 2023-01-12 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54771-8550-1 | Temaril-P | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 54771-8550-2 | Temaril-P | 1000 in 1 BOTTLE | TABLET | 1000 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54771-8550 | TEMARIL-P (TRIMEPRAZINE TARTRATE AND PREDNISOLONE) TABLET [ZOETIS INC.] | 7 | 2 package rows | 20230113_9de07d0d-44df-47da-b4b7-24f5fc803b46.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| prednisolone | ACTIVE INGREDIENT | 9PHQ9Y1OLM | TEMARIL-P (TRIMEPRAZINE TARTRATE AND PREDNISOLONE) TABLET [ZOETIS INC] | 1 | |
| trimeprazine tartrate | ACTIVE INGREDIENT | 362NW1LD6Z | TEMARIL-P (TRIMEPRAZINE TARTRATE AND PREDNISOLONE) TABLET [ZOETIS INC] | 1 | |
| prednisolone | ACTIVE MOIETY | 9PHQ9Y1OLM | TEMARIL-P (TRIMEPRAZINE TARTRATE AND PREDNISOLONE) TABLET [ZOETIS INC] | 1 | |
| trimeprazine | ACTIVE MOIETY | 76H78MJJ52 | TEMARIL-P (TRIMEPRAZINE TARTRATE AND PREDNISOLONE) TABLET [ZOETIS INC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prednisolone | PREDNISOLONE ORAL | TRUPHARMA, LLC | 4f83514d-5342-4748-a0d3-b0306ca303c8 | 2026-09-02 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE ORAL | Tulex Pharmaceuticals Inc | 757b41c4-a0fe-4a09-8816-a4cdb7558f41 | 2026-07-08 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE | A-S Medication Solutions | 35f0b197-c3ae-445a-8da7-9ffcd4472e05 | 2026-01-23 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| PREDNISOLONE | PREDNISOLONE | Zhejiang Xianju Pharmaceutical Co., Ltd. | 52e6e21d-94b8-41a0-8d13-371c0e66bcee | 2026-01-05 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE ORAL | Chartwell Governmental & Specialty RX, LLC. | 2dac9898-6492-4f34-ad86-83a902e0fe0b | 2025-11-18 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE ORAL SOLUTION | Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. | b079834f-9aa3-4db9-bd53-de28e8f81c04 | 2025-02-18 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE | PAI Holdings, LLC dba PAI Pharma | cebd7b5b-8e9f-4de9-9fcf-8ee0661fede3 | 2024-08-19 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| PREDNISOLONE | PREDNISOLONE | Hisun Pharmaceuticals USA, Inc. | 16d4e064-66d3-4497-8c7d-3aa355f91e1d | 2024-08-15 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE | Chartwell RX, LLC | 2e965355-f7f2-4dd3-9c5c-1524c6f39c91 | 2024-06-17 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| Prednisolone | PREDNISOLONE ORAL | Chartwell RX, LLC | aa40f582-cced-4e6e-90f0-10ab310ab2a7 | 2024-06-03 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| PREDNISOLONE | PREDNISOLONE | Aurobindo Pharma Limited | 070f1937-50a5-457f-bef5-4e597014e26d | 2024-02-16 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
| PrednisoLONE | PREDNISOLONE | Lannett Company, Inc. | 86652e2d-664a-4388-a611-c2a9aa4a4bc8 | 2024-02-14 | Warnings, Adverse reactions | 9PHQ9Y1OLM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.